flow trial semaglutide nejm kidney outcomes hazard ratio 0.76 2024 Semaglutides Are Poised to Remake Chronic Kidney Disease Care SELECT Trial

Pre-existing cardiac conditions : Ozempic may be prescribed to patients with established cardiovascular disease

There was also a 3-fold reduction in IL-10 after L-GSH supplementation in every category when compared to the control category before L-GSH supplementation ( Figure 7B )

But the drug became a blockbuster when patients and doctors discovered that, in addition to helping with diabetes, the drug also causes people to lose a significant amount of weight

Tirzepatide Weight Loss Results Similar to semaglutide, tirzepatide users can expect to lose between 15 and 20% of their body weight depending on the maintenance dose